BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 11961250)

  • 21. Mapping and Engineering Functional Domains of the Assembly-Activating Protein of Adeno-associated Viruses.
    Tse LV; Moller-Tank S; Meganck RM; Asokan A
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29695425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the Assembly-Activating Protein on Molecular Evolution of Synthetic Adeno-Associated Virus Capsids.
    Herrmann AK; Große S; Börner K; Krämer C; Wiedtke E; Gunkel M; Grimm D
    Hum Gene Ther; 2019 Jan; 30(1):21-35. PubMed ID: 29978729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phospholipase A2 activity-dependent stimulation of Ca2+ entry by human parvovirus B19 capsid protein VP1.
    Lupescu A; Bock CT; Lang PA; Aberle S; Kaiser H; Kandolf R; Lang F
    J Virol; 2006 Nov; 80(22):11370-80. PubMed ID: 16956939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.
    Wu P; Xiao W; Conlon T; Hughes J; Agbandje-McKenna M; Ferkol T; Flotte T; Muzyczka N
    J Virol; 2000 Sep; 74(18):8635-47. PubMed ID: 10954565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A viral assembly factor promotes AAV2 capsid formation in the nucleolus.
    Sonntag F; Schmidt K; Kleinschmidt JA
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10220-5. PubMed ID: 20479244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in the carboxy terminus of adeno-associated virus 2 capsid proteins affect viral infectivity: lack of an RGD integrin-binding motif.
    Ruffing M; Heid H; Kleinschmidt JA
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3385-92. PubMed ID: 7996133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for packaging of rep-cap sequences into adeno-associated virus (AAV) type 2 capsids in the absence of inverted terminal repeats: a model for generation of rep-positive AAV particles.
    Nony P; Chadeuf G; Tessier J; Moullier P; Salvetti A
    J Virol; 2003 Jan; 77(1):776-81. PubMed ID: 12477885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parvoviral virions deploy a capsid-tethered lipolytic enzyme to breach the endosomal membrane during cell entry.
    Farr GA; Zhang LG; Tattersall P
    Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17148-53. PubMed ID: 16284249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and characterization of nuclear and nucleolar localization signals in the adeno-associated virus serotype 2 assembly-activating protein.
    Earley LF; Kawano Y; Adachi K; Sun XX; Dai MS; Nakai H
    J Virol; 2015 Mar; 89(6):3038-48. PubMed ID: 25552709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformational changes in adeno-associated virus type 1 induced by genome packaging.
    Gerlach B; Kleinschmidt JA; Böttcher B
    J Mol Biol; 2011 Jun; 409(3):427-38. PubMed ID: 21463638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini.
    Kronenberg S; Böttcher B; von der Lieth CW; Bleker S; Kleinschmidt JA
    J Virol; 2005 May; 79(9):5296-303. PubMed ID: 15827144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular and Structural Characterization of VP1 and VP2 Knockout Mutants of AAV3B Serotype and Implications for AAV Manufacturing.
    Arriaga I; Navarro A; Etxabe A; Trigueros C; Samulski RJ; Moullier P; François A; Abrescia NGA
    Hum Gene Ther; 2022 Nov; 33(21-22):1142-1156. PubMed ID: 36082996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A viral phospholipase A2 is required for parvovirus infectivity.
    Zádori Z; Szelei J; Lacoste MC; Li Y; Gariépy S; Raymond P; Allaire M; Nabi IR; Tijssen P
    Dev Cell; 2001 Aug; 1(2):291-302. PubMed ID: 11702787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of a pore in the capsid of JC polyomavirus reduces infectivity and prevents exposure of the minor capsid proteins.
    Nelson CD; Ströh LJ; Gee GV; O'Hara BA; Stehle T; Atwood WJ
    J Virol; 2015 Apr; 89(7):3910-21. PubMed ID: 25609820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding.
    Opie SR; Warrington KH; Agbandje-McKenna M; Zolotukhin S; Muzyczka N
    J Virol; 2003 Jun; 77(12):6995-7006. PubMed ID: 12768018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Truncation of the nuclear localization signal of polyomavirus VP1 results in a loss of DNA packaging when expressed in the baculovirus system.
    Gillock ET; An K; Consigli RA
    Virus Res; 1998 Nov; 58(1-2):149-60. PubMed ID: 9879771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adeno-associated viruses having nonsense mutations in the capsid genes: growth in mammalian cells containing an inducible amber suppressor.
    Smuda JW; Carter BJ
    Virology; 1991 Sep; 184(1):310-8. PubMed ID: 1651593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids.
    King JA; Dubielzig R; Grimm D; Kleinschmidt JA
    EMBO J; 2001 Jun; 20(12):3282-91. PubMed ID: 11406604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of six-His-tagged peptide to the C terminus of adeno-associated virus VP3 does not affect viral tropism or production.
    Zhang HG; Xie J; Dmitriev I; Kashentseva E; Curiel DT; Hsu HC; Mountz JD
    J Virol; 2002 Dec; 76(23):12023-31. PubMed ID: 12414944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.